NEW YORK CITY (Reuters) – Morgan Stanley has actually boosted its 12-month base instance rate …
Read More »Advisory Panel of Experts Endorses FDA Approval of New Alzheimer’s Drug
A committee of independent advisers to the Food and Drug Administration voted unanimously Monday that the benefits outweigh the risks of the newest experimental drug for Alzheimer’s disease. Alzheimer’s afflicts more than 6 million Americans. It has no cure, and there is no treatment or lifestyle modification that can restore memory loss or reverse cognitive decline. The drug, made by …
Read More »